A multi-institutional, cross-sectional study using the EORTC QLQ-TC26 for patients with testicular cancer
| Project/Area Number |
18K09185
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Review Section |
Basic Section 56030:Urology-related
|
|---|
| Research Institution | Tohoku University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
山下 慎一 東北大学, 大学病院, 講師 (10622425)
荒井 陽一 東北大学, 医学系研究科, 名誉教授 (50193058)
鈴鴨 よしみ 東北大学, 医学系研究科, 准教授 (60362472)
三塚 浩二 東北大学, 医学系研究科, 准教授 (80568171)
嶋田 修一 東北大学, 大学病院, 助教 (80749218)
|
|---|
| Project Period (FY) |
2018-04-01 – 2021-03-31
|
| Project Status |
Completed (Fiscal Year 2020)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2020: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2019: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2018: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Keywords | 精巣癌 / がんサバイバー / ＱＯＬ / ＥＯＲＴＣ ＱＬＱ－ＴＣ２６ / QOL / 質問票 |
|---|
| Outline of Final Research Achievements |
In 2013, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Testicular Cancer 26 (EORTC QLQ-TC26) was developed by the EORTC QOL group. The Japanese version of the EORTC QLQ-TC26 questionnaire was validated in Japanese-speaking testicular cancer (TC) survivors. In addition, the health-related QOL of TC survivors was evaluated using the Japanese version of the EORTC QLQ-TC26 questionnaire in a multi-institutional, cross-sectional study in Japan.
The psychometric properties of the Japanese version were equivalent to the properties of the original EORTC QLQ-TC26. Moreover, TC survivors were anxious about not only cancer recurrence, but also their jobs and education, especially one year after treatment.
|
| Academic Significance and Societal Importance of the Research Achievements |
本研究は本邦における精巣がんサバイバーを対象にした初めての大規模なＱＯＬ研究である。今回の妥当性検証でＥＯＲＴＣ ＱＬＱ－ＴＣ２６日本語版は本邦の精巣癌患者に特異的な健康関連ＱＯＬを評価する有用なツールになり得ることが明らかとなった。さらに、今回得られた精巣がんサバイバーの実態調査の結果をサバイバーシップに活用することで治療後の不安を軽減させ精巣癌患者のＱＯＬ向上につながる可能性がある。
本研究で用いたＥＯＲＴＣ ＱＬＱ－ＴＣ２６の質問票はいくつもの言語への翻訳作業が進められており、今後国際比較を含めて精巣癌患者のＱＯＬ向上を目指した治療法の開発に役立つことが期待できる。
|
Report
(4 results)
Research Products
(10 results)
-
[Journal Article] Validation study of the Japanese version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Testicular Cancer 26 for patients with testicular cancer.2021
Author(s)
Yamashita S, Suzukamo Y, Kakimoto K, Uemura M, Kishida T, Kawai K, Nakamura T, Goto T, Osawa T, Yamada S, Nishimura K, Nonomura N, Nishiyama H, Shiraishi T, Ukimura O, Ogawa O, Shinohara N, Ito A, Arai Y
-
Journal Title
Int J Urol
Volume: 28
Issue: 2
Pages: 176-182
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
